Myriad Genetics Inc (NASDAQ:MYGN)

21.20
Delayed Data
As of May 18
 -1.45 / -6.40%
Today’s Change
18.98
Today|||52-Week Range
36.95
-23.19%
Year-to-Date

Today’s Trading

Previous close22.65
Today’s open22.11
Day’s range21.01 - 22.60
Volume802,800
Average volume (3 months)548,876
Market cap$1.8B
Data as of 4:01pm ET, 05/18/2022

Growth & Valuation

Earnings growth (last year)+87.01%
Earnings growth (this year)-1,050.00%
Earnings growth (next 5 years)+6.00%
Revenue growth (last year)+8.14%
P/E ratioNM
Price/Sales3.12
Price/Book1.85

Competitors

----
CLDXCelldex Therapeutics...-1.87-6.01%
CDNACareDx Inc-2.02-7.99%
VCYTVeracyte Inc-1.27-7.29%
Data as of 4:27pm ET, 05/18/2022

Financials

Next reporting dateAugust 2, 2022
EPS forecast (this quarter)$0.03
Annual revenue (last year)$690.6M
Annual profit (last year)-$27.2M
Net profit margin-3.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts